IMBdx
Healthcare Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
21 131 가산디지털1로 층, Seoul, Geumcheon-gu, S...Phone Number
+61 269512906Website
www.imbdx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About IMBdx
IMBdx is a pioneering company in precision medicine, specializing in innovative liquid biopsy platforms that integrate artificial intelligence and genomics for cancer screening. Their flagship product, AlphaLiquid, offers advanced cancer monitoring and screening solutions, validated through extensive clinical trials. The company provides clinical services for patients, research support for biopharma, and health screening services for the general public. IMBdx aims to enhance treatment plans and accelerate drug development processes in oncology.Explore more
IMBdx Org Chart
MP
Global Director, Business Development
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is IMBdx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on IMBdx recently announced quarterly report
Product Launch: Get notified when IMBdx launches new products
Check out if IMBdx is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if IMBdx has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
IMBdx, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once IMBdx has new funding data
Congratulate Masked Content for being promoted to Masked Content at IMBdx
Click to see if IMBdx had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined IMBdx as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
IMBdx is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
IMBdx is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about IMBdx.
IMBdx Tech Stack
A closer look at the technologies used by IMBdx
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events
Event
will be attending the Medlab Middle East 2023 conference as an exhibitor. The event will occur from February 6 to February 9, 2023.
Event
IMBdx News & Media
IMBdx Expands Targeted Therapies Agreement Following Successful Evaluation of Blood-Based Genomic Profiling Assay in Prostate Cancer
SEOUL, South Korea, June 8, 2023 /PRNewswire/ -- IMBdx Inc., a premier precision cancer diagnostic company accredited by CAP, announced today its plans to broaden its collaboration with AstraZeneca, a leading global biopharmaceutical company. This expansion will advance the shift from...
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IMBdx
Sign Up For FreeTo access detailed company insights
IMBdx is a pioneering company in precision medicine, specializing in innovative liquid biopsy platforms that integrate artificial intelligence and genomics for cancer screening. Their flagship product, AlphaLiquid, offers advanced cancer monitoring and screening solutions, validated through extensive clinical trials. The company provides clinical s... Read More
